127 related articles for article (PubMed ID: 33964126)
1. Serum angiopoietin-2 levels in dogs with splenic haemangiosarcoma, haemangioma, and splenitis.
Wongsuttawas S; Brikshavana P; Durongphongtorn S; Techangamsuwan S
Acta Vet Hung; 2021 May; 69(1):55-66. PubMed ID: 33964126
[TBL] [Abstract][Full Text] [Related]
2. Big endothelin-1 as a tumour marker for canine haemangiosarcoma.
Fukumoto S; Miyasho T; Hanazono K; Saida K; Kadosawa T; Iwano H; Uchide T
Vet J; 2015 Jun; 204(3):269-74. PubMed ID: 25920760
[TBL] [Abstract][Full Text] [Related]
3. Breed prevalence and sites of haemangioma and haemangiosarcoma in dogs.
Srebernik N; Appleby EC
Vet Rec; 1991 Nov; 129(18):408-9. PubMed ID: 1767484
[No Abstract] [Full Text] [Related]
4. Hyperferritinemia in dogs with splenic hemangiosarcoma.
Chikazawa S; Hori Y; Hoshi F; Kanai K; Ito N; Higuchi S
J Vet Med Sci; 2013 Nov; 75(11):1515-8. PubMed ID: 23803459
[TBL] [Abstract][Full Text] [Related]
5. Serum vascular endothelial growth factor in dogs with haemangiosarcoma and haematoma.
Frenz M; Kaup FJ; Neumann S
Res Vet Sci; 2014 Oct; 97(2):257-62. PubMed ID: 25241388
[TBL] [Abstract][Full Text] [Related]
6. An immunohistochemical analysis of canine haemangioma and haemangiosarcoma.
Sabattini S; Bettini G
J Comp Pathol; 2009; 140(2-3):158-68. PubMed ID: 19091326
[TBL] [Abstract][Full Text] [Related]
7. A review of pathological diagnoses made from 87 canine splenic biopsies.
Day MJ; Lucke VM; Pearson H
J Small Anim Pract; 1995 Oct; 36(10):426-33. PubMed ID: 8583757
[TBL] [Abstract][Full Text] [Related]
8. Occurrence and Clinicopathologic Features of Splenic Neoplasia Based on Body Weight: 325 Dogs (2003-2013).
Sherwood JM; Haynes AM; Klocke E; Higginbotham ML; Thomson EM; Weng HY; Towle Millard HA
J Am Anim Hosp Assoc; 2016; 52(4):220-6. PubMed ID: 27259024
[TBL] [Abstract][Full Text] [Related]
9. Development of perioperative premature ventricular contractions as an indicator of splenic hemangiosarcoma and median survival times.
Panissidi AA; DeSandre-Robinson DM
Vet Surg; 2021 Nov; 50(8):1609-1616. PubMed ID: 34351008
[TBL] [Abstract][Full Text] [Related]
10. Does thalidomide prolong survival in dogs with splenic haemangiosarcoma?
Bray JP; Orbell G; Cave N; Munday JS
J Small Anim Pract; 2018 Feb; 59(2):85-91. PubMed ID: 29210452
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Detection of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor in Canine Vascular Endothelial Tumours.
Anwar Sh; Yanai T; Sakai H
J Comp Pathol; 2015 Nov; 153(4):278-82. PubMed ID: 26286429
[TBL] [Abstract][Full Text] [Related]
12. Refining the "double two-thirds" rule: Genotype-based breed grouping and clinical presentation help predict the diagnosis of canine splenic mass lesions in 288 dogs.
Davies O; Taylor AJ
Vet Comp Oncol; 2020 Dec; 18(4):548-558. PubMed ID: 32043696
[TBL] [Abstract][Full Text] [Related]
13. Concurrent splenic and right atrial mass at presentation in dogs with HSA: a retrospective study.
Boston SE; Higginson G; Monteith G
J Am Anim Hosp Assoc; 2011; 47(5):336-41. PubMed ID: 21852509
[TBL] [Abstract][Full Text] [Related]
14. Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs.
Lana S; U'ren L; Plaza S; Elmslie R; Gustafson D; Morley P; Dow S
J Vet Intern Med; 2007; 21(4):764-9. PubMed ID: 17708397
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of conjunctival hemangioma and hemangiosarcoma: A retrospective study of 52 dogs.
Richardson S; Deykin AR
Vet Ophthalmol; 2021 Sep; 24(5):432-441. PubMed ID: 34402571
[TBL] [Abstract][Full Text] [Related]
16. Canine splenic haemangiosarcoma: influence of metastases, chemotherapy and growth pattern on post-splenectomy survival and expression of angiogenic factors.
Göritz M; Müller K; Krastel D; Staudacher G; Schmidt P; Kühn M; Nickel R; Schoon HA
J Comp Pathol; 2013 Jul; 149(1):30-9. PubMed ID: 23276383
[TBL] [Abstract][Full Text] [Related]
17. Prospective observational study of dogs with splenic mass rupture suggests potentially lower risk of malignancy and more favourable perioperative outcomes.
Stewart SD; Ehrhart EJ; Davies R; Khanna C
Vet Comp Oncol; 2020 Dec; 18(4):811-817. PubMed ID: 32458544
[TBL] [Abstract][Full Text] [Related]
18. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.
Vail DM; MacEwen EG; Kurzman ID; Dubielzig RR; Helfand SC; Kisseberth WC; London CA; Obradovich JE; Madewell BR; Rodriguez CO
Clin Cancer Res; 1995 Oct; 1(10):1165-70. PubMed ID: 9815908
[TBL] [Abstract][Full Text] [Related]
19. Splenic masses in dogs. Part 1: Epidemiologic, clinical characteristics as well as histopathologic diagnosis in 249 cases (2000-2011).
Eberle N; von Babo V; Nolte I; Baumgärtner W; Betz D
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):250-60. PubMed ID: 22911256
[TBL] [Abstract][Full Text] [Related]
20. German shepherds and splenic tumours.
Dome SH; Staton JF
Vet Rec; 1978 Mar; 102(10):224. PubMed ID: 565554
[No Abstract] [Full Text] [Related]
[Next] [New Search]
